Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

Elan gets FDA approval for Tysabri MS treatment LONDON (CBS.MW) -- Elan (UK:ELA) (ELN) and partner Biogen (BIIB) said the FDA has approved new drug Tysabri to treat relapsing forms of multiple sclerosis.
